Filtered By:
Source: Frontiers in Pharmacology
Condition: Disability
Drug: Actos

This page shows you your search results in order of date.

Order by Relevance | Date

Total 1 results found since Jan 2013.

Activation of the PPAR γ Prevents Ferroptosis-Induced Neuronal Loss in Response to Intracerebral Hemorrhage Through Synergistic Actions With the Nrf2
Intracerebral hemorrhage (ICH) is a subtype of stroke characterized by high mortality and disability rates. The long-term effects of ICH-induced intracranial hematoma on patients’ neurological function are unclear. Currently, an effective treatment that significantly reduces the rates of death and disability in patients with ICH is not available. Based on accumulating evidence, ferroptosis may be the leading factor contributing to the neurological impairment caused by ICH injury. Peroxisome proliferator-activated receptor γ (PPARγ) is a ligand-activated receptor in the nuclear hormone receptor family that synergistical...
Source: Frontiers in Pharmacology - April 20, 2022 Category: Drugs & Pharmacology Source Type: research